Navigation Links
Marshall Edwards Announces Private Placement
Date:5/2/2011

SAN DIEGO, May 2, 2011 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that it has entered into a definitive agreement with certain institutional investors to sell in a private placement common stock and warrants for gross proceeds of up to $4 million, before deducting fees and expenses of the offering, of which approximately $1.1 million would result from the sale of approximately 835,217 shares of common stock at $1.333 per share. The remaining $2.9 million would be subject to the exercise of one-year series B warrants at their initial exercise price of $1.333 per share and the fulfillment or waiver of certain conditions.

The Company will also issue series A warrants which will initially represent the right to purchase up to 626,413 shares of common stock exercisable after six months for a period of five years and subject to proportionate increases to the extent the series B warrants are exercised. Series C warrants may entitle the holders to obtain additional shares of common stock exercisable in the event the trading price of the common stock is below certain levels on specified future dates during a period of up to one year following the closing date.

The offering is expected to close on or about May 13, 2011, subject to certain customary closing conditions as well as the closing of the transactions contemplated by the asset purchase agreement entered into between the Company and its majority shareholder, Novogen Limited, and Novogen Research Pty Limited on December 21, 2010, which is pending approval at a meeting of Novogen shareholders on May 6, 2011.

The net proceeds from the offering will be used primarily to continue development of Marshall Edwards' two lead oncology programs, including a Phase I clinical trial of its intr
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
2. Marshall Edwards Receives Positive Response From NASDAQ
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
5. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
6. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
7. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
8. Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
9. Esperion Announces Results From Phase 1 Study and Four Preclinical Studies for ETC-1002
10. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... TOKYO , April 21, 2015  EBD ... has just announced Medtech Partnering Forum 2015 , ... industry. The event, held May 28–29 in ... medtech partnering conference in Japan . ... developments in the rapidly changing medical technology industry in ...
(Date:4/21/2015)... 21, 2015 Amgen (NASDAQ: AMGN ) ... 2015. Key results include: , Total revenues increased ... $5,033 million, with 12 percent product sales growth driven ... (denosumab), EPOGEN ® (epoetin alfa), Sensipar ® ... foreign exchange rates impacted total revenue and product sales ...
(Date:4/21/2015)... April 21, 2015  Inmark,s acquisition of Saf-T-Pak ... Dangerous Goods Training, specifically Division 6.2.  For over ... Goods training programs focusing on IATA, ICAO, US ... regulations. "We were particularly interested in ... their multilingual internet training programs," said David ...
Breaking Medicine Technology:Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 2Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 4Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 2Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 3Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 4Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 5Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 6Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 7Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 8Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 9Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 10Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 11Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 12Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 13Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 14Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 15Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 16Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 17Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 18Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48 19Inmark's Acquisition Of Saf-T-Pak Results In Expansion Of Its Dangerous Goods Training Portfolio 2
... 21, 2012  Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Phase 1 clinical program with their investigational product ... targeting PCSK9 (proprotein convertase subtilisin/kexin type 9 serine ... issue of the New England Journal of ...
... 2012   Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: ... owned subsidiary Healthcare Distribution Specialist, LLC ("HDS") are pleased ... the Diet, Vitamin & Sports Nutrition Expo to be ... Fort Lauderdale, Florida on July 15-17, 2012.  As part ...
Cached Medicine Technology:Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 2Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 3Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 4Sunpeaks Ventures to Participate in ECRM Conference and Expo 2Sunpeaks Ventures to Participate in ECRM Conference and Expo 3
(Date:4/21/2015)... The International Journal of Chronic ... “ COPD and its association with smoking in the ... and women from ten diverse areas ”. , As ... smoke ~40% of the world’s cigarettes, but the substantial ... too recent for the full eventual health consequences to ...
(Date:4/21/2015)... April 21, 2015 My Patriot Supply ... offer the latest innovation in home water filtration: ... filtration system that makes existing gravity-fed filters obsolete. An ... federal and industry standards for water filtration. With an ... for a typical household. , The Alexapure Pro™ takes ...
(Date:4/21/2015)... On April 2, 2015, Elle Magazine, in ... Jenner Lips With Disastrous Results,” reported that ... attempting an at-home lip augmentation process. The ... an airlock around one’s mouth for several minutes will ... Kylie Jenner’s now famous pout. (see: goo.gl/dFQW2L) , “Truth ...
(Date:4/21/2015)... 2015 “ ZeroWire ” was featured ... which takes a look at the latest and coolest ... a special reporter for NewsWatch and a technology expert, ... is a security system and lifestyle management hub. , ... over 2 million burglaries in 2010. It goes without ...
(Date:4/21/2015)... Phoenix, AZ and Lewisville, TX (PRWEB) April 21, 2015 ... and Adeptus Health (NYSE:ADPT) announced today it is opening ... facility will be located in Chandler, Arizona and will ... is also part of the Dignity Health and Adeptus ... of Dignity Health Chandler Regional and Mercy Gilbert Medical ...
Breaking Medicine News(10 mins):Health News:COPD and smoking in the Mainland China published by Dove Medical Press 2Health News:COPD and smoking in the Mainland China published by Dove Medical Press 3Health News:Preparedness Leader My Patriot Supply Unveils the New Alexapure Pro™ Water Filter 2Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3
... PITTSBURGH , Jan. 28 Developing comprehensive ... will be the subject of the annual spring conference of ... is part of UPMC and based in Pittsburgh . ... Young Adults and Families," will put special emphasis on successful ...
... , Jan. 28 DNA Medicine Institute, ... innovation, today announced it has been awarded a Phase ... National Aeronautics and Space Administration (NASA).  The contract is ... health analysis in a single drop of blood.  The ...
... The nectar of the almond tree produces an extraordinary and ... this poison in its flowers, nectar. A study carried out ... mysteriously drawn to the toxic substance. Has the almond ... group of researchers at the Department of Environmental and Evolutionary ...
... ... Bowl advertising throughout the economic ups and downs of the decade. , ... Pennington, NJ (PRWEB) January 28, 2010 -- In ... the market research firm, Gallup & Robinson, Inc., overall attitudes towards Super Bowl advertising have ...
... not always a benefit, study of seniors suggests , THURSDAY, ... overweight will kill you, a new Australian study finds that ... to die over a 10-year period than their normal-weight peers. ... of the American Geriatrics Society , conflicts with research that ...
... , Crohn,s & Colitis Foundation of America ... Scored During the 2009 Season , NEW YORK , ... America (CCFA) today announced the culmination of the second consecutive year ... David Garrard , quarterback of the Jacksonville Jaguars ® (1) ...
Cached Medicine News:Health News:Community Care Hosts Conference on Behavioral Health Services for Children 2Health News:Community Care Hosts Conference on Behavioral Health Services for Children 3Health News:NASA selects DNA Medicine Institute's Nanoscale Diagnostics Technology for Phase II SBIR 2Health News:The almond tree's secret weapon 2Health News:The almond tree's secret weapon 3Health News:Super Bowl Advertising, In Good Times And Bad 2Health News:Super Bowl Advertising, In Good Times And Bad 3Health News:Over 70 and Overweight May Add Years to Life 2Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 2Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 3Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 4
... Prep Pads are known ... including bacteria, fungi, viruses, ... Iodine is virtually non-irritating ... mucus membranes. It is ...
BETADINE Solution Swab Aid antiseptic pads are for quick and easy skin degerming. Individually wrapped pads, saturated with 10% povidone-iodine solution, offer the advantages of BETADINE Solution in ...
... offer convenience, low cost, ease of use. The ... package is terminally sterilized, ensuring the safest possible ... Pads prepare the skin for improved adhesion of ... a thin film on the skin's surface. This ...
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Medicine Products: